Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis

´ëÇÑÇ÷¾×ÇÐȸÁö 2014³â 49±Ç 2È£ p.100 ~ p.106

(Malik Mohsin Ilyas) - Mayo Clinic Department of Medicine
(Litzow Mark) - Mayo Clinic Department of Medicine
(William Hogan) - Mayo Clinic Department of Medicine
(Patnaik Mrinal) - Mayo Clinic Department of Medicine
(Shahrukh Hashmi) - Mayo Clinic Department of Medicine
(Murad Mohammad Hassan) - Mayo Clinic Occupation and Aerospace Medicine
(Prokop Larry J.) - Mayo Clinic Library and Public Services
(Winters Jeffrey L.) - Mayo Clinic Department of Laboratory Medicine and Pathology

Abstract

Background: The safety of extracorporeal photopheresis (ECP) in steroid-refractory chronic graft-ver-sus-host disease (SR-cGVHD) has been explored in multiple studies but reported re-sponse rates (RR) vary significantly across studies.

Methods: We conducted a meta-analysis to assess the efficacy of ECP for SR-cGVHD. A search of electronic databases for studies published between 1984 and 2012 was conducted. End points included RR: complete response (CR), overall response rates (ORR), and or-gan-specific RR. The initial search generated 312 studies, of which 18 met the selection criteria (N=595). A random effects model was used for pooled rates.

Results: Pooled CR rates and ORR were 29% (confidence interval [CI], 19?42%) and 64% (CI, 65?82%), respectively. One-year overall survival was available for 4 studies only and was 49% (CI, 29?70%). The pooled RR for skin, liver, ocular, oral, lung, gastrointestinal and muscu-loskeletal SR-cGVHD was 74%, 68%, 60%, 72%, 48%, 53%, and 64%, respectively. There was a significant heterogeneity among studies due to differences in ECP schedules and duration. No significant differences in responses to ECP for pediatric and adult pop-ulations were found. Sensitivity analysis could not be undertaken due to a limited number of prospective studies.

Conclusion: ECP is an effective therapy for oral, skin, and liver SR-cGVHD, with modest activity in lung and gastrointestinal SR-cGVHD.

Å°¿öµå

Graft-versus-host disease, Extracorporeal photopheresis, Meta-analysis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå